Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New developments on thromboxane modulators.

Jean-Michel Dogné1, Julien Hanson, Xavier de Leval

  • 1Natural and Synthetic Drug Research Centre, Medicinal Chemistry, University of Liège, 1, av. de l'Hôpital, B-4000 Liège, Belgium. Jean-Michel.Dogne@ulg.ac.be

Mini Reviews in Medicinal Chemistry
|July 29, 2004
PubMed
Summary

Thromboxane A(2) (TXA(2)) plays a role in cardiovascular and thromboembolic diseases. This review details the development of TXA(2) modulators over two decades.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized Trials in Pregnancy.

JAMA·2026
Same author

Kainate Receptor Allosteric Modulators: State of the Art and Future Directions.

ChemMedChem·2026
Same author

Potential risk of neoplasms with fezolinetant: clinical evidence, mechanisms, and post-marketing implications.

Journal of the Endocrine Society·2026
Same author

Techniques for measuring NETosis: A critical literature review and outlook for standardization.

Thrombosis research·2026
Same author

Why Pediatric CAR-T Therapies Still Lag Behind: Insights from Six Treatments Centrally Approved in Europe.

Clinical pharmacology and therapeutics·2026
Same author

Commentary: 1-year risks of cancers associated with COVID-19 vaccination: a large population-based cohort study in South Korea.

Frontiers in public health·2026

Area of Science:

  • Biochemistry
  • Pharmacology
  • Cardiovascular Science

Background:

  • Thromboxane A(2) (TXA(2)), a metabolite of arachidonic acid, is implicated in cardiovascular, pulmonary, and thromboembolic diseases.
  • The biological significance of TXA(2) has driven research into therapeutic interventions.

Purpose of the Study:

  • To review the historical development and evolution of Thromboxane A(2) modulators.
  • To provide an overview of the scientific advancements in TXA(2) modulation strategies.

Main Methods:

  • Literature review of scientific publications.
  • Analysis of research trends in TXA(2) modulator development over the past 20 years.

Main Results:

  • Significant progress has been made in understanding TXA(2) pathways.

Related Experiment Videos

  • Various TXA(2) modulators have been investigated and developed.

    • Conclusions:

    • TXA(2) modulators represent a key area of therapeutic development for related diseases.
    • Continued research into TXA(2) modulation holds promise for future treatments.